• Japanese
  • Korean
  • Chinese
Cover Image

Analysis of Emerging Cancer Diagnostic Tests and Strategic Profile of Leading Suppliers

Abstract

Description

This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.

The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications.

The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 286 pages and 28 tables

Table of Contents

Major Current And Emerging Cancer Diagnostic Tests

1. Introduction

2. Tumor Marker Classification

3. ACTH

4. Alpha-Fetoprotein (AFP)

5. Beta-2 Microglobulin

6. CA 15-3/27.29

7. CA 19-9

8. CA-125

9. Calcitonin

10. Carcinoembrionic Antigen (CEA)

11. Estrogen and Progesterone Receptors

12. Ferritin

13. Gastrin

14. Human Chorionic Gonadotropin (HCG)

15. Insulin

16. NSE

17. Occult Blood

18. PAP Smear/HPV

19. Prostatic Acid Phosphatase (PAP)

20. Prostate-Specific Antigen (PSA)

21. Squamous Cell Carcinoma Antigen (SCC)

22. T and B Lymphocytes

23. TdT

24. Thyroglobulin

25. Tissue Polypeptide Antigen (TPA)

26. Biochemical Tumor Markers

  • ADA
  • B-Protein
  • PNP
  • 5'-Nucleotidase

27. Oncogenes

  • Abl/abl-bcr
  • AIB1
  • BCL-2
  • BRCA1
  • CD44
  • C-fos
  • C-myb
  • C-myc
  • CYP-17
  • Erb-B
  • HPC1
  • N-myc
  • P40
  • P51
  • P53
  • PIK3CA
  • PTI-1
  • Ras
  • Reg
  • Sis
  • Src

28. Polypeptide Growth Factors

  • Basic Fibroblast Growth Factor
  • Beta-TGF
  • Cachectin (TNT)
  • Calmodulin
  • ECFR
  • Nerve Growth Factor (NGF)
  • Epidermal Growth Factor (EGF)
  • Ornithine Decarboxylase
  • Transferrin
  • Transforming Growth Factor-Alpha

29. Ectopic Hormones

30. Colony Stimulating Factors

31. Lymphokines

  • Alpha-Interferon
  • B Cell Growth Factors
  • B Cell Growth Factor (BCGF)
  • Gamma-Interferon
  • Interleukin-1 (IL-1)
  • Macrophage Activating Factor

32. Immunohistochemical Stains

33. Emerging Tumor Markers

  • N-Acetylglucosamine
  • Actin
  • Alpha-Actin
  • Antineuronal Antibodies
  • 7B2
  • B72.3
  • Bax
  • BCD-F9
  • BLCA-4
  • Blood Group Antigens A,B,H
  • CA 50
  • CA 72-4/TAG-72
  • CA 195
  • CA-242
  • CA-549
  • CAM 26
  • CAR-3
  • Cathepsin-D
  • Chromogranin A and B
  • Cluster 1 Antigen
  • Cluster-5/5A Antigen
  • CTA
  • CU18
  • DR-70
  • DU-PAN-2
  • Endometrial Bleeding Associated Factor
  • Endostatin
  • Epithelial Membrane Antigen
  • Feulgen Hydrolysis
  • Fibronectin
  • FSH
  • (1->3)-L-fucosyltransferase
  • Gastrin-Releasing Peptide (GRP)
  • GDCFP-15
  • Glucagon
  • Glycoamines
  • H23
  • Her-2
  • Human Carcinoma Antigen
  • HPA
  • HSP27
  • Intermediate Filaments
  • Cytokeratins/CK18/Cyfra 21-1
  • Desmin
  • Gliofibrillary Acid Protein
  • Neurofilaments
  • Vimentin
  • KA 93
  • Kinases
  • KP16D3
  • LAI
  • Leukocyte Common Antigen
  • Lewis Antigens
  • Lysophosphatidic Acid (LPA)
  • Ma 695/Ma 552
  • MABDF3
  • MAG
  • ME1
  • Minactivin
  • MN/CA9
  • MSA
  • Mucin Cancer Antigen (MCA)
  • Multiple Tumor Suppressor 1
  • Myosin
  • NEA-130
  • NMP22
  • OA-519
  • Opiod Peptides
  • P-glycoprotein
  • Pancreatic Oncofetal Antigen (POA)
  • Placental Lactogen
  • PR92
  • Proliferative Index, Ki-67
  • Px
  • RB Inactivation/Deletion
  • Ret
  • SCCL 175
  • Selectin
  • Sialic Acid
  • Sialyl SSEA-1/SLX
  • SN10
  • Somatostatin
  • TA-90
  • TABA
  • Tachykinin
  • TAG 12
  • TPS
  • Troponin
  • Tubulin
  • VCAM
  • VEGF
  • Villen

Competitive Profiles

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Correlogic Systems
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Ipsogen
  • Kreatech
  • Kyowa Medex
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

Appendixes

  • Appendix I: Major Universities and Research
  • Centers Developing Cancer Diagnostic
  • Technology and Applications

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or MarketingCA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Show More
RELATED REPORTS
* Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
  • Published:
  • Jun 26, 2014
  • USD 15900
  • 1200 Pages

* New Frontiers in the German Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape
  • Published:
  • May 02, 2014
  • USD 4350
  • 585 Pages

* New Frontiers in the Japanese Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape
  • Published:
  • May 02, 2014
  • USD 5700
  • 590 Pages

* New Frontiers in the US Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape
  • Published:
  • May 02, 2014
  • USD 6400
  • 620 Pages

* Competitive Intelligence 2014: Analyses of Current and Emerging Suppliers of Immunodiagnositcs, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents
  • Published:
  • Mar 03, 2014
  • USD 8500

* German Cancer Diagnostics Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies
  • Published:
  • Jan 08, 2014
  • USD 4350

* German Hospital Cancer Diagnostics Market 2014
  • Published:
  • Jan 08, 2014
  • USD 2500

* Japanese Cancer Diagnostics Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies
  • Published:
  • Jan 08, 2014
  • USD 4900

* Japanese Hospital Cancer Diagnostics Market 2014
  • Published:
  • Jan 08, 2014
  • USD 3200

* UK Cancer Diagnostics Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies
  • Published:
  • Jan 08, 2014
  • USD 4350

Browse more In Vitro Diagnostics Market Research Reports

Pricing
Get Notified
Email me when related reports are published